Skip to main content
Clinical Trials/NCT05535816
NCT05535816
Terminated
Not Applicable

Diagnostic Accuracy of Ultrasound Versus Fluoroscopy for Detecting Residual Fragments During Retrograde Intrarenal Surgery: a Randomized Controlled Trial

University of California, San Francisco1 site in 1 country40 target enrollmentMarch 27, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stone, Kidney
Sponsor
University of California, San Francisco
Enrollment
40
Locations
1
Primary Endpoint
Diagnostic accuracy detecting residual fragments during retrograde intrarenal surgery
Status
Terminated
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to assess the accuracy of ultrasound and traditional fluoroscopy to find the residual fragments before retrograde intrarenal surgery is complete. This would ultimately limit the need for radiation exposure and improve the quality of clinical care given to patients and healthcare teams.

Detailed Description

Ultrasound is currently gaining popularity as an alternative imaging modality for the diagnosis and treatment of urolithiasis. However, the benefit of ultrasound on the diagnostic accuracy of detecting residual fragments during retrograde intrarenal surgery (RIRS) has never been evaluated in a randomized study. Its use would reduce radiation exposure for patients and care team members as well as improve stone free clearance rates for surgery. Therefore, The investigators plan to conduct a randomized trial to assess the diagnostic accuracy of ultrasound and fluoroscopy in conjunction with endoscopic examination for detecting residual stone fragments during retrograde intrarenal surgery. After admission, approximately 172 subjects will be randomized in a 1:1 ratio to receive ultrasound or fluoroscopy before completing RIRS. Subsequently, four weeks after the operation, the investigators will compare with routine low-dose non-contrast computed tomography as a gold standard for detecting residual fragments. If ultrasound is more accurate than fluoroscopy in detecting residual fragments, the investigators will encourage this approach as it can reduce radiation exposure for patients and healthcare professionals.

Registry
clinicaltrials.gov
Start Date
March 27, 2023
End Date
December 18, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients over the age of
  • Consecutive patients with a diagnosis of renal stone or ureteral stone with a plan to undergoing RIRS for stone removal.

Exclusion Criteria

  • Patients who decline informed consent.
  • Pregnancy
  • Kidney transplantation
  • Ectopic kidney
  • Patients undergoing concurrent bilateral stone removal surgery.
  • Patients whose pain cannot be controlled when presenting at the Emergency Department.

Outcomes

Primary Outcomes

Diagnostic accuracy detecting residual fragments during retrograde intrarenal surgery

Time Frame: 4 weeks

The diagnostic accuracy of ultrasound and fluoroscopy will be measured in conjunction with endoscopic examination for detecting residual fragments during retrograde intrarenal surgery for renal stones treatment by the same endourologist to determine the size of the largest residual fragment, categorizing them as stone free, ≤ 2 mm, or \>2 mm, and compared with routine low-dose non-contrast computed tomography by a radiologist blinded to surgery and intraoperative imaging, categorizing them as stone free, ≤ 2 mm, or \>2 mm. The results will be compared for accuracy.

Secondary Outcomes

  • Specificity detecting residual fragments during retrograde intrarenal surgery(4 weeks)
  • Operative time in minutes(Surgical duration, up to 4 hours)
  • Sensitivity detecting residual fragments during retrograde intrarenal surgery(4 weeks)
  • Positive predictive value detecting residual fragments during retrograde intrarenal surgery(4 weeks)
  • Negative predictive value detecting residual fragments during retrograde intrarenal surgery(4 weeks)
  • Surgical complications into grade I to V on the modified Clavien-Dindo classification from operation, up to 4 weeks.(From operation, up to 4 weeks)

Study Sites (1)

Loading locations...

Similar Trials